AU2001262943A1 - Methods for drug discovery, disease treatment, and diagnosis using metabolomics - Google Patents
Methods for drug discovery, disease treatment, and diagnosis using metabolomicsInfo
- Publication number
- AU2001262943A1 AU2001262943A1 AU2001262943A AU6294301A AU2001262943A1 AU 2001262943 A1 AU2001262943 A1 AU 2001262943A1 AU 2001262943 A AU2001262943 A AU 2001262943A AU 6294301 A AU6294301 A AU 6294301A AU 2001262943 A1 AU2001262943 A1 AU 2001262943A1
- Authority
- AU
- Australia
- Prior art keywords
- metabolomics
- diagnosis
- methods
- drug discovery
- disease treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Physiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biophysics (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Oncology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
Applications Claiming Priority (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US19711700P | 2000-04-14 | 2000-04-14 | |
US19708500P | 2000-04-14 | 2000-04-14 | |
US60197085 | 2000-04-14 | ||
US60197117 | 2000-04-14 | ||
US23954100P | 2000-10-10 | 2000-10-10 | |
US60239541 | 2000-10-10 | ||
US23934000P | 2000-10-11 | 2000-10-11 | |
US60239340 | 2000-10-11 | ||
PCT/US2001/012097 WO2001078652A2 (en) | 2000-04-14 | 2001-04-13 | Methods for drug discovery, disease treatment, and diagnosis using metabolomics |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001262943A1 true AU2001262943A1 (en) | 2001-10-30 |
Family
ID=27498145
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001262943A Abandoned AU2001262943A1 (en) | 2000-04-14 | 2001-04-13 | Methods for drug discovery, disease treatment, and diagnosis using metabolomics |
Country Status (6)
Country | Link |
---|---|
US (3) | US20020009740A1 (de) |
EP (2) | EP2330219A3 (de) |
JP (2) | JP2003530130A (de) |
AU (1) | AU2001262943A1 (de) |
CA (1) | CA2443806A1 (de) |
WO (1) | WO2001078652A2 (de) |
Families Citing this family (94)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2298181C (en) * | 2000-02-02 | 2006-09-19 | Dayan Burke Goodnough | Non-targeted complex sample analysis |
CA2443806A1 (en) | 2000-04-14 | 2002-10-25 | Metabolon, Inc. | Methods for drug discovery, disease treatment, and diagnosis using metabolomics |
US7329489B2 (en) | 2000-04-14 | 2008-02-12 | Matabolon, Inc. | Methods for drug discovery, disease treatment, and diagnosis using metabolomics |
DE10054055A1 (de) | 2000-10-31 | 2002-05-23 | Nmi Univ Tuebingen | Verfahren zur Analyse von Proteinen |
US20040023295A1 (en) * | 2001-11-21 | 2004-02-05 | Carol Hamilton | Methods and systems for analyzing complex biological systems |
CA2477909A1 (en) * | 2002-03-11 | 2003-09-25 | Lipomics Technologies, Inc. | Novel metabolic targets and markers |
US7460960B2 (en) | 2002-05-10 | 2008-12-02 | Epitome Biosystems, Inc. | Proteome epitope tags and methods of use thereof in protein modification analysis |
US7618788B2 (en) | 2002-05-10 | 2009-11-17 | Millipore Corporation | Proteome epitope tags and methods of use thereof in protein modification analysis |
US9740817B1 (en) | 2002-10-18 | 2017-08-22 | Dennis Sunga Fernandez | Apparatus for biological sensing and alerting of pharmaco-genomic mutation |
AU2003286726A1 (en) * | 2002-10-25 | 2004-05-13 | Metabolon, Inc. | Methods for drug discovery, disease treatment, and diagnosis using metabolomics |
EP2357581A3 (de) | 2002-12-09 | 2012-09-12 | Ajinomoto Co., Inc. | Vorrichtung und Verfahren zur Verarbeitung von Informationen im Zusammenhang mit biologischen Zuständen, System, Programm und Aufzeichnungsmedium zur Verwaltung von Informationen im Zusammenhang mit biologischen Zuständen |
US20050143628A1 (en) * | 2003-06-18 | 2005-06-30 | Xudong Dai | Methods for characterizing tissue or organ condition or status |
US8346482B2 (en) | 2003-08-22 | 2013-01-01 | Fernandez Dennis S | Integrated biosensor and simulation system for diagnosis and therapy |
US20050059023A1 (en) * | 2003-09-16 | 2005-03-17 | Cantor Thomas L. | Methods and kits for monitoring resistance to therapeutic agents |
JP2007528487A (ja) * | 2003-10-23 | 2007-10-11 | ユニヴァーシティ オヴ ピッツバーグ オヴ ザ コモンウェルス システム オヴ ハイアー エデュケーション | 筋萎縮性側索硬化症に対するバイオマーカー |
WO2005050224A2 (en) * | 2003-11-13 | 2005-06-02 | Epitome Biosystems Inc. | Small molecule and peptide arrays and uses thereof |
EP1853894A1 (de) * | 2005-02-22 | 2007-11-14 | McGill University | Vorrichtung zur messung von oxidativem stress sowie damit verbundene verfahren |
WO2006112841A1 (en) * | 2005-04-19 | 2006-10-26 | The Scripps Research Institute | Methods for metabolite profiling |
JP5020491B2 (ja) * | 2005-05-02 | 2012-09-05 | 株式会社 Jeol Resonance | Nmrデータの処理装置及び方法 |
US8265877B2 (en) * | 2005-06-30 | 2012-09-11 | Biocrates Life Sciences Ag | Apparatus and method for analyzing a metabolite profile |
US7433787B2 (en) * | 2005-08-08 | 2008-10-07 | Metabolon, Inc. | System, method, and computer program product using a database in a computing system to compile and compare metabolomic data obtained from a plurality of samples |
US7949475B2 (en) | 2005-08-08 | 2011-05-24 | Metabolon Inc. | System and method for analyzing metabolomic data |
SG182169A1 (en) | 2005-09-12 | 2012-07-30 | Phenomenome Discoveries Inc | Method for the diagnosis of colorectal cancer and ovarian cancer by the measurement of vitamin e-related metabolites |
WO2007050318A2 (en) * | 2005-10-24 | 2007-05-03 | Duke University | Lipidomics approaches for central nervous system disorders |
US7981399B2 (en) * | 2006-01-09 | 2011-07-19 | Mcgill University | Method to determine state of a cell exchanging metabolites with a fluid medium by analyzing the metabolites in the fluid medium |
ES2431291T3 (es) * | 2006-01-10 | 2013-11-25 | Colgate-Palmolive Company | Métodos para modular receptores de superficie celular para prevenir o reducir la inflamación |
EP1998789A4 (de) | 2006-02-28 | 2009-04-22 | Metabolon Inc | Biomarker für amyotrophe lateralsklerose und verwendungsverfahren dafür |
AU2013273746A1 (en) * | 2006-02-28 | 2014-02-20 | Phenomenome Discoveries Inc. | Methods for the diagnosis of dementia and other neurological disorders |
CA2689848A1 (en) | 2006-02-28 | 2007-09-07 | Phenomenome Discoveries Inc. | Methods for the diagnosis of dementia and other neurological disorders |
US7561975B2 (en) * | 2006-03-21 | 2009-07-14 | Metabolon, Inc. | System, method, and computer program product for analyzing spectrometry data to identify and quantify individual components in a sample |
US7855057B2 (en) | 2006-03-23 | 2010-12-21 | Millipore Corporation | Protein splice variant/isoform discrimination and quantitative measurements thereof |
EP2674435A3 (de) | 2006-03-24 | 2014-04-30 | Phenomenome Discoveries Inc. | Biomarker zur Diagnose von Prostatakrebs und Verfahren dafür |
US8518926B2 (en) * | 2006-04-10 | 2013-08-27 | Knopp Neurosciences, Inc. | Compositions and methods of using (R)-pramipexole |
US8137977B2 (en) * | 2006-04-24 | 2012-03-20 | Children's Hospital & Research Center At Oakland | Lipidomic approaches to determining drug response phenotypes in cardiovascular disease |
WO2007127192A2 (en) * | 2006-04-24 | 2007-11-08 | Duke University | Lipidomic approaches to determining drug response phenotypes in cardiovascular disease |
US8394354B2 (en) * | 2006-05-09 | 2013-03-12 | Metabolon, Inc. | Biomarkers for depression and methods using the same |
WO2007137071A2 (en) | 2006-05-16 | 2007-11-29 | Knopp Neurosciences, Inc. | Compositions of r(+) and s(-) pramipexole and methods of using the same |
EP2644588A3 (de) * | 2006-05-26 | 2013-12-25 | Phenomenome Discoveries Inc. | Biomarker zur Diagnose von Multipler Sklerose und Verfahren dafür |
JPWO2008015929A1 (ja) * | 2006-08-04 | 2009-12-24 | 味の素株式会社 | メタボリック・シンドロームの評価方法、メタボリック・シンドローム評価装置、メタボリック・シンドローム評価方法、メタボリック・シンドローム評価システム、メタボリック・シンドローム評価プログラムおよび記録媒体、ならびにメタボリック・シンドロームの予防・改善物質の探索方法 |
JP5856364B2 (ja) | 2006-08-04 | 2016-02-09 | 味の素株式会社 | 抑うつ病の評価方法、抑うつ病評価装置、抑うつ病評価方法、抑うつ病評価システム、抑うつ病評価プログラム、記録媒体および端末装置 |
US20080183101A1 (en) * | 2006-08-17 | 2008-07-31 | Jonathan Richard Stonehouse | Salivary analysis |
US8849577B2 (en) * | 2006-09-15 | 2014-09-30 | Metabolon, Inc. | Methods of identifying biochemical pathways |
WO2008036691A2 (en) * | 2006-09-19 | 2008-03-27 | Metabolon, Inc. | Biomarkers for prostate cancer and methods using the same |
US20090075284A1 (en) * | 2006-09-19 | 2009-03-19 | The Regents Of The University Of Michigan | Metabolomic profiling of prostate cancer |
EP2813580A1 (de) | 2006-10-13 | 2014-12-17 | Metabolon, Inc. | Mit metabolischem Alter verbundene Biomarker und Verfahren zur Verwendung davon |
EP1923806A1 (de) * | 2006-11-14 | 2008-05-21 | Metanomics GmbH | Schnelle, metabolomische Analyse und System dafür |
US8524695B2 (en) * | 2006-12-14 | 2013-09-03 | Knopp Neurosciences, Inc. | Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same |
AU2007346587C1 (en) | 2007-02-08 | 2015-01-22 | Med-Life Discoveries Lp | Methods for the treatment of Senile Dementia of the Alzheimer's Type |
PT2129396E (pt) | 2007-02-16 | 2013-11-18 | Merrimack Pharmaceuticals Inc | Anticorpos contra erbb3 e suas utilizações |
AU2008224844B2 (en) | 2007-03-14 | 2012-08-09 | Knopp Neurosciences, Inc. | Synthesis of chirally purified substituted benzothiazole diamines |
JP5116348B2 (ja) * | 2007-04-12 | 2013-01-09 | 花王株式会社 | 被験物質の評価又はスクリーニング方法 |
JP2010527449A (ja) * | 2007-05-15 | 2010-08-12 | ブライハム アンド ウィミンズ ホスピタル,インコーポレーテッド | プロテオームにおける酸化修飾ペプチド配列の同定 |
EP2515116A1 (de) * | 2007-05-18 | 2012-10-24 | Duke University | Serum-Biomarker für den frühen Nachweis von Lungenkrebs |
JPWO2009001862A1 (ja) | 2007-06-25 | 2010-08-26 | 味の素株式会社 | 内臓脂肪蓄積の評価方法 |
JP5701601B2 (ja) | 2007-07-17 | 2015-04-15 | メタボロン インコーポレイテッド | 糖尿病前症、心血管疾患及びその他のメタボリックシンドローム関連障害のバイオマーカー並びにその使用方法 |
AU2008289172B2 (en) * | 2007-08-16 | 2013-01-17 | Metabolon, Inc. | Metabolomic profiling of prostate cancer |
EP2209001A4 (de) * | 2007-10-25 | 2010-10-27 | Ajinomoto Kk | Verfahren zur beurteilung von gestörter glucosetoleranz |
EP2546649B1 (de) | 2007-11-02 | 2015-02-25 | Metabolon Inc. | Biomarker für Fettleberkrankheit und Verfahren zur Verwendung davon |
EP2279417B1 (de) * | 2008-05-28 | 2016-07-20 | Georgia Tech Research Corporation | Stoffwechsel-biomarker für eierstockkrebs und anwendungsverfahren dafür |
CA2734491A1 (en) | 2008-08-19 | 2010-02-25 | Knopp Neurosciences, Inc. | Compositions and methods of using (r)-pramipexole |
EP2337617A4 (de) * | 2008-10-09 | 2013-06-12 | Bioparadox Llc | Plättchenreiche plasmaformulierungen für herzbehandlungen |
AR076177A1 (es) | 2009-04-01 | 2011-05-26 | Colgate Palmolive Co | MÉTODO PARA IDENTIFICAR UN COMPUESTO uTIL PARA TRATAR UNA ENFERMEDAD O CONDICIoN DE LA CAVIDAD ORAL |
RU2492857C2 (ru) | 2009-04-01 | 2013-09-20 | Колгейт-Палмолив Компани | Соединения - производные ментола и их применение в качестве активных системных агентов и агентов для ротовой полости |
TWI481870B (zh) | 2009-04-01 | 2015-04-21 | Colgate Palmolive Co | 用於軟組織疾病診斷及作為用於口腔保健干預的標靶之蛋白質生物標記 |
JP2012522771A (ja) | 2009-04-01 | 2012-09-27 | コルゲート・パーモリブ・カンパニー | 口腔ケア組成物における使用のための抗バイオフィルムカーボネート化合物 |
WO2011041656A2 (en) | 2009-10-02 | 2011-04-07 | Metabolon Inc. | Apparatus and associated method for analyzing small molecule components in a complex mixture |
US20110151497A1 (en) * | 2009-12-22 | 2011-06-23 | The Regents Of The University Of Michigan | Metabolomic profiling of prostate cancer |
PL2544680T3 (pl) | 2010-03-11 | 2015-08-31 | Merrimack Pharmaceuticals Inc | Zastosowanie inhibitorów ERBB1 w leczeniu potrójnie ujemnego raka gruczołu sutkowego |
WO2011130385A1 (en) | 2010-04-13 | 2011-10-20 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Servic | Biomarkers for hepatocellular cancer |
WO2013096816A1 (en) | 2011-12-22 | 2013-06-27 | Biogen Idec Ma Inc. | Improved synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds |
JP5920827B2 (ja) * | 2012-06-21 | 2016-05-18 | 国立研究開発法人農業・食品産業技術総合研究機構 | 病害抵抗性品種系統の識別方法 |
EP2901392B1 (de) * | 2012-09-25 | 2018-11-07 | Google LLC | Sicherung personalisierter identifikationsnummern für mobilzahlungsanwendungen durch kombination mit zufallskomponenten |
JP6404834B2 (ja) | 2013-01-31 | 2018-10-17 | メタボロン,インコーポレイテッド | インスリン抵抗性の進行に関連するバイオマーカー及びこれを使用する方法 |
US9662313B2 (en) | 2013-02-28 | 2017-05-30 | Knopp Biosciences Llc | Compositions and methods for treating amyotrophic lateral sclerosis in responders |
EP3019624B1 (de) | 2013-07-09 | 2020-09-16 | Stemina Biomarker Discovery, Inc. | Biomarker für autismusspektrumsstörungen |
DK3019167T3 (da) | 2013-07-12 | 2021-03-15 | Knopp Biosciences Llc | Behandling af forhøjede niveauer af eosinophiler og/eller basophiler |
US9468630B2 (en) | 2013-07-12 | 2016-10-18 | Knopp Biosciences Llc | Compositions and methods for treating conditions related to increased eosinophils |
EP3033081B1 (de) | 2013-08-13 | 2021-05-12 | Knopp Biosciences LLC | Zusammensetzungen und verfahren zur behandlung von chronischer nesselsucht |
WO2015023786A1 (en) | 2013-08-13 | 2015-02-19 | Knopp Biosciences Llc | Compositions and methods for treating plasma cell disorders and b-cell prolymphocytic disorders |
EP3087394A2 (de) | 2013-12-27 | 2016-11-02 | Merrimack Pharmaceuticals, Inc. | Biomarkerprofile zur vorhersage der ergebnisse einer krebstherapie mit erbb3-inhibitoren und/oder chemotherapien |
WO2015157407A1 (en) | 2014-04-08 | 2015-10-15 | Metabolon, Inc. | Small molecule biochemical profiling of individual subjects for disease diagnosis and health assessment |
EP3149762A1 (de) | 2014-05-30 | 2017-04-05 | Metabolon, Inc. | Verfahren zur analyse kleinmoleküliger komponenten einer komplexen mischung in einem multiprobenverfahren sowie zugehörige vorrichtung und computerprogrammprodukt |
JP2017536543A (ja) * | 2014-11-05 | 2017-12-07 | メタボロン,インコーポレイテッド | 遺伝的変異体の影響を決定するためのシステム、方法、および装置 |
JP2018502286A (ja) | 2014-11-19 | 2018-01-25 | メタボロン,インコーポレイテッド | 脂肪肝疾患のバイオマーカーおよびその使用方法 |
WO2016126923A1 (en) | 2015-02-06 | 2016-08-11 | Metabolon, Inc. | Diagnostic methods, therapeutic agents and uses thereof |
US10184006B2 (en) | 2015-06-04 | 2019-01-22 | Merrimack Pharmaceuticals, Inc. | Biomarkers for predicting outcomes of cancer therapy with ErbB3 inhibitors |
JP6747095B2 (ja) * | 2016-06-24 | 2020-08-26 | ブラザー工業株式会社 | 情報処理プログラムおよび情報処理装置 |
US11154619B2 (en) | 2017-02-17 | 2021-10-26 | Creighton University | Liposomal compositions with light illumination-induced drug release |
WO2019104146A1 (en) * | 2017-11-22 | 2019-05-31 | Mayo Foundation For Medical Education And Research | Methods and materials for assessing and treating obesity |
EP3724654B1 (de) | 2017-12-15 | 2024-04-24 | Metabolon, Inc. | Verfahren zur analyse kleinmoleküliger komponenten einer komplexen mischung und zugehörige vorrichtung und computerprogrammprodukt |
WO2019195638A1 (en) | 2018-04-04 | 2019-10-10 | Human Longevity, Inc. | Systems and methods for measuring obesity using metabolome analysis |
US11693005B2 (en) | 2018-08-07 | 2023-07-04 | Florida Atlantic University Board Of Trustees | Methods for identifying treatments that reduce the actions of substances of abuse and addiction |
US20200116657A1 (en) * | 2018-10-15 | 2020-04-16 | Olaris, Inc. | Nmr-metabolite-signature for identifying cancer patients resistant to cdk4/6 inhibitors, endocrine therapy and anti-her2 therapy |
US20230137741A1 (en) | 2021-11-01 | 2023-05-04 | Matterworks Inc | Methods and compositions for analyte quantification |
Family Cites Families (77)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE32920E (en) | 1978-01-11 | 1989-05-09 | Esa, Inc. | Electrochemical testing system and method |
US6210970B1 (en) * | 1980-01-14 | 2001-04-03 | Esa, Inc. | Method of diagnosing or categorizing disorders from biochemical profiles |
US6194217B1 (en) * | 1980-01-14 | 2001-02-27 | Esa, Inc. | Method of diagnosing or categorizing disorders from biochemical profiles |
US4863873A (en) * | 1980-01-14 | 1989-09-05 | Esa, Inc. | Method for biological testing and/or developing pharmaceuticals for treatment of disorders |
US4511659A (en) * | 1983-03-04 | 1985-04-16 | Esa, Inc. | Liquid chromatograph with electrochemical detector and method |
US5104639A (en) * | 1980-01-14 | 1992-04-14 | Esa, Inc. | Method for biological testing and/or developing pharmaceuticals for treatment of disorders using electrochromatography |
DE3587091T2 (de) | 1984-11-13 | 1993-06-03 | Esa Inc | Entwicklungsverfahren fuer arzneimittel zur behandlung von stoerungen. |
US5272057A (en) | 1988-10-14 | 1993-12-21 | Georgetown University | Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase |
US5143854A (en) | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
ATE199054T1 (de) | 1990-12-06 | 2001-02-15 | Affymetrix Inc A Delaware Corp | Verbindungen und ihre verwendung in einer binären synthesestrategie |
EP0567564B1 (de) | 1991-01-18 | 1996-10-16 | ESA, Inc. | Verfahren zur Diagnose von Störungen der Körperfunktionen unter Verwendung von biochemischen Pryfilen |
US5977083A (en) * | 1991-08-21 | 1999-11-02 | Burcoglu; Arsinur | Method for using polynucleotides, oligonucleotides and derivatives thereof to treat various disease states |
DE59208894D1 (de) | 1991-12-02 | 1997-10-16 | Riemschneider Randolph Prof Dr | Wässrige synthetische Organextrakte |
US5290420A (en) | 1992-08-12 | 1994-03-01 | Esa, Inc. | Sampling system and analysis cell for stripping voltammetry |
US5541310A (en) * | 1993-05-13 | 1996-07-30 | Ciba-Geigy Corporation | Herbicide resistant plants |
US5861242A (en) | 1993-06-25 | 1999-01-19 | Affymetrix, Inc. | Array of nucleic acid probes on biological chips for diagnosis of HIV and methods of using the same |
US6027880A (en) | 1995-08-02 | 2000-02-22 | Affymetrix, Inc. | Arrays of nucleic acid probes and methods of using the same for detecting cystic fibrosis |
US5536639A (en) * | 1994-03-25 | 1996-07-16 | Cephalon, Inc. | Methods for detecting calpain activation by detection of calpain activated spectrin breakdown products |
US5565323A (en) * | 1994-03-30 | 1996-10-15 | Mitokor | Cytochrome oxidase mutations aiding diagnosis of sporadic alzheimer's disease |
WO1996023075A1 (en) | 1995-01-23 | 1996-08-01 | Microcide Pharmaceuticals, Inc. | Screening for modulators of biomolecules |
US6319668B1 (en) * | 1995-04-25 | 2001-11-20 | Discovery Partners International | Method for tagging and screening molecules |
US5908609A (en) | 1996-06-10 | 1999-06-01 | Millennium Pharmaceuticals, Inc. | Screening methods for compounds useful in the regulation of body weight |
DE19624802A1 (de) * | 1996-06-21 | 1998-01-02 | Forssmann Wolf Georg | Verfahren zum direkten diagnostischen Nachweis von pathogenen, genetisch bedingten Punktmutationen in Proteinen bei Herzerkrankungen durch chemische und physikalische Methoden, besonders der direkten und indirekten Kopplung der Hochdruck-Flüssigkeitschromatographie und der Massenspektrometrie |
GB9700012D0 (en) * | 1997-01-02 | 1997-02-19 | Aromascan Plc | Improvements in the detection of bacteria |
US6087090A (en) * | 1997-02-25 | 2000-07-11 | Celtrix Pharmaceuticals, Inc. | Methods for predicting drug response |
US5824467A (en) | 1997-02-25 | 1998-10-20 | Celtrix Pharmaceuticals | Methods for predicting drug response |
WO1999027361A1 (en) | 1997-11-20 | 1999-06-03 | Esa, Inc. | Electrochemical analysis system |
CA2314422A1 (en) | 1997-12-18 | 1999-06-24 | Sepracor Inc. | Methods for the simultaneous identification of novel biological targets and lead structures for drug development |
TR200002166T2 (tr) | 1998-01-22 | 2001-03-21 | National Research Council Of Canada | Bitkilerdeki ikincil metabolik bileşiklerin değişim seviyeleri için yöntem ve düzenlemeler. |
DE19802576B4 (de) * | 1998-01-23 | 2004-10-28 | Xerion Pharmaceuticals Ag | Verfahren zur gleichzeitigen Identifizierung von Proteinen und ihren Bindungspartnern |
AU740830B2 (en) | 1998-01-29 | 2001-11-15 | Glaucus Proteomics B.V. | High density arrays for proteome analysis and methods and compositions therefor |
EP1066517B1 (de) * | 1998-02-25 | 2006-11-29 | THE UNITED STATES GOVERNMENT as represented by THE DEPARTMENT OF HEALTH AND HUMAN SERVICES | Zellulare anordnungen für schnelle molekulare profilidentifizierung |
WO1999050437A1 (en) * | 1998-03-30 | 1999-10-07 | Esa, Inc. | Methodology for predicting and/or diagnosing disease |
US6004755A (en) * | 1998-04-07 | 1999-12-21 | Incyte Pharmaceuticals, Inc. | Quantitative microarray hybridizaton assays |
US6218117B1 (en) * | 1998-06-15 | 2001-04-17 | Mitokor | Compositions and methods for identifying agents that quantitatively alter detectable extramitochondrial DNA:mitochondrial DNA ratios |
CA2339817A1 (en) * | 1998-08-12 | 2000-02-24 | Zycos Inc. | Profiling and cataloging expressed protein tags |
US20030049613A1 (en) * | 1998-08-17 | 2003-03-13 | Manuel Perucho | Methods for identifying somatic changes in genomic sequences useful for cancer diagnosis and prognosis |
US6344322B1 (en) * | 1998-08-20 | 2002-02-05 | The Johns Hopkins University | Subtle mitochondrial mutations as tumor markers |
US6053866A (en) | 1998-10-29 | 2000-04-25 | Mcleod; Malcolm N. | Method for facilitating diagnosis of a psychiatric disorder |
US6258605B1 (en) * | 1999-03-26 | 2001-07-10 | Neo Gen Screening, Inc. | Clinical method for the genetic screening of newborns using tandem mass spectrometry |
AU2054000A (en) | 1999-02-26 | 2000-09-14 | Lipomed, Inc. | Methods, systems, and computer program products for analyzing and presenting risk assessment results based on nmr lipoprotein analysis of blood |
WO2000055346A2 (en) | 1999-03-17 | 2000-09-21 | Paradigm Genetics, Inc. | Methods and materials for the rapid and high volume production of a gene knock-out library in an organism |
CA2371385A1 (en) | 1999-04-26 | 2000-11-02 | Surromed, Inc. | Phenotype and biological marker identification system |
WO2000065039A2 (en) | 1999-04-28 | 2000-11-02 | Syngenta Participations Ag | Identification of dna control elements responsive to specific stimuli |
US6168933B1 (en) * | 1999-06-08 | 2001-01-02 | Incyte Pharmaceuticals, Inc. | Phospholipid transfer protein |
WO2001000819A1 (en) | 1999-06-25 | 2001-01-04 | Chauhan, Sarita | Targeted gene replacements in enteric bacteria using linear dna |
US6376210B1 (en) * | 1999-07-06 | 2002-04-23 | General Atomics | Methods and compositions for assaying analytes |
US6350588B1 (en) * | 1999-07-20 | 2002-02-26 | Micrology Laboratories, Llc | Test media and quantitative or qualitative method for identification and differentiation of biological materials in a test sample |
DE19935967A1 (de) * | 1999-07-30 | 2001-02-01 | Bayer Ag | Verfahren zur Bestimmung der Aktivität von 1-Desoxy-D-Xylulose-5-Phosphat-Reduktionsomerase und 1-Desoxy-D-Xylulose-5-Phosphat-Synthase |
EP1204756A2 (de) | 1999-07-30 | 2002-05-15 | Bayer Aktiengesellschaft | Verfahren zur bestimmung der 1-desoxy-d-xylulose-5-phosphat reduktoisomerase - und 1-desoxy-d-xylulose-5-phosphat synthase - aktivität |
ATE289090T1 (de) | 1999-08-03 | 2005-02-15 | Paradigm Genetics Inc | Methodologie um pflanzen und andere organismen mit von der normalen probe abweichenden charakteristiken zu identifizieren |
WO2001018627A2 (en) | 1999-09-06 | 2001-03-15 | National University Of Singapore | Method and apparatus for computer automated detection of protein and nucleic acid targets of a chemical compound |
ATE437845T1 (de) | 1999-09-29 | 2009-08-15 | Nerviano Medical Sciences Srl | Verfahren zur herstellung einer verbindungsbibliothek und identifizierung von lead chemischen templaten und liganden von zielmolekülen |
US6677160B1 (en) * | 1999-09-29 | 2004-01-13 | Pharmacia & Upjohn Company | Methods for creating a compound library and identifying lead chemical templates and ligands for target molecules |
AU781806B2 (en) | 1999-09-30 | 2005-06-16 | University Of Guelph | Novel enzymes and metabolites involved in skatole metabolism |
US7225082B1 (en) | 1999-10-01 | 2007-05-29 | Oxonica, Inc. | Colloidal rod particles as nanobar codes |
AU2064001A (en) | 1999-12-06 | 2001-06-12 | National Center For Genome Resources | System and method for metabolic profiling |
US6566086B1 (en) | 2000-01-28 | 2003-05-20 | Fal Diagnostics | Diagnostic kit for detecting creatine levels |
US20040053322A1 (en) | 2000-01-31 | 2004-03-18 | Mcdevitt John T. | System and method for the analysis of bodily fluids |
CA2298181C (en) | 2000-02-02 | 2006-09-19 | Dayan Burke Goodnough | Non-targeted complex sample analysis |
GB2360282A (en) | 2000-03-17 | 2001-09-19 | Bioinvent Int Ab | Making and using micro-arrays of biological materials |
US7356417B2 (en) | 2000-03-28 | 2008-04-08 | Monsanto Company | Methods, systems and computer program products for dynamic scheduling and matrix collecting of data about samples |
US6617494B2 (en) | 2000-04-12 | 2003-09-09 | Paradigm Genetics, Inc. | Methods for identifying transgenic plants using morphological markers |
CA2443806A1 (en) | 2000-04-14 | 2002-10-25 | Metabolon, Inc. | Methods for drug discovery, disease treatment, and diagnosis using metabolomics |
US7329489B2 (en) | 2000-04-14 | 2008-02-12 | Matabolon, Inc. | Methods for drug discovery, disease treatment, and diagnosis using metabolomics |
SE0001670D0 (sv) | 2000-05-04 | 2000-05-04 | Forskarpatent I Syd Ab | Mass-spectrometry-based biosensor |
EP1299398A1 (de) * | 2000-07-06 | 2003-04-09 | Fal Diagnostics | Verfahren und kits für die detektion von argininverbindungen |
US6680203B2 (en) | 2000-07-10 | 2004-01-20 | Esperion Therapeutics, Inc. | Fourier transform mass spectrometry of complex biological samples |
US6326164B1 (en) * | 2000-07-27 | 2001-12-04 | Paradigm Genetics, Inc. | Methods for determining deoxyxylulose 5-phosphate synthase activity |
US20020034827A1 (en) | 2000-08-01 | 2002-03-21 | Rajendra Singh | Methods for solid phase nanoextraction and desorption |
WO2002033377A2 (en) | 2000-09-20 | 2002-04-25 | Surromed, Inc. | Biological markers for evaluating therapeutic treatment of inflammatory and autoimmune disorders |
GB0031566D0 (en) | 2000-12-22 | 2001-02-07 | Mets Ometrix | Methods for spectral analysis and their applications |
WO2002086452A2 (en) | 2001-03-23 | 2002-10-31 | President And Fellows Of Harvard College | Selective deposition of materials on contoured surfaces |
CA2444740A1 (en) | 2001-04-23 | 2002-10-31 | Metabometrix Limited | Methods for analysis of spectral data and their applications: osteoarthritis |
EP1444524A2 (de) | 2001-09-14 | 2004-08-11 | Paradigm Genetics Inc. | Verfahren zur identifizierung von modulatoren der magnesium chelatase-aktivität und -expression in pflanzen |
AU2003286726A1 (en) | 2002-10-25 | 2004-05-13 | Metabolon, Inc. | Methods for drug discovery, disease treatment, and diagnosis using metabolomics |
WO2006086731A2 (en) | 2005-02-09 | 2006-08-17 | The Gov't.T Of The Usa As Represented By The Secretary Of The Department Of Health & Human Services | Method for identifying the risk of preterm delivery |
-
2001
- 2001-04-13 CA CA002443806A patent/CA2443806A1/en not_active Abandoned
- 2001-04-13 US US09/835,119 patent/US20020009740A1/en not_active Abandoned
- 2001-04-13 JP JP2001575955A patent/JP2003530130A/ja active Pending
- 2001-04-13 EP EP10183052A patent/EP2330219A3/de not_active Withdrawn
- 2001-04-13 EP EP01937180A patent/EP1285092A4/de not_active Withdrawn
- 2001-04-13 WO PCT/US2001/012097 patent/WO2001078652A2/en active Application Filing
- 2001-04-13 AU AU2001262943A patent/AU2001262943A1/en not_active Abandoned
-
2004
- 2004-01-13 US US10/757,616 patent/US7005255B2/en not_active Expired - Lifetime
-
2006
- 2006-02-17 US US11/357,732 patent/US7635556B2/en not_active Expired - Lifetime
-
2012
- 2012-04-02 JP JP2012083678A patent/JP2012185166A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
US7005255B2 (en) | 2006-02-28 |
JP2012185166A (ja) | 2012-09-27 |
EP1285092A4 (de) | 2003-07-16 |
EP2330219A3 (de) | 2011-11-23 |
WO2001078652A2 (en) | 2001-10-25 |
EP2330219A2 (de) | 2011-06-08 |
CA2443806A1 (en) | 2002-10-25 |
US7635556B2 (en) | 2009-12-22 |
WO2001078652A3 (en) | 2002-02-07 |
US20020009740A1 (en) | 2002-01-24 |
EP1285092A2 (de) | 2003-02-26 |
US20040146853A1 (en) | 2004-07-29 |
JP2003530130A (ja) | 2003-10-14 |
US20070026389A1 (en) | 2007-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001262943A1 (en) | Methods for drug discovery, disease treatment, and diagnosis using metabolomics | |
AU2001275177A1 (en) | Cardiac disease treatment and device | |
AU2001275176A1 (en) | Cardiac disease treatment and device | |
AU2001253565A1 (en) | Cardiac disease treatment and device | |
AU2001281369A1 (en) | Cardiac disease treatment and device | |
AU2001240753A1 (en) | Lipid nanocapsules, preparation method and use as medicine | |
HK1061679A1 (en) | Phenylsulfonyl-1,3-dihydro-2h-indole-2-ibe derivatives, their preparation and their therapeutic use. | |
AU2001227837A1 (en) | Novel treatment for eye disease | |
AU2001241963A1 (en) | Improved medical procedure | |
AU2002340999A1 (en) | Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use | |
AU2002338265A1 (en) | Molecules for disease detection and treatment | |
AU2003286726A1 (en) | Methods for drug discovery, disease treatment, and diagnosis using metabolomics | |
AU2001264042A1 (en) | 1,4-diazabicyclo(3.2.2)nonane-phenylisoxazole derivatives, preparation and therapeutic use thereof | |
AU2000265525A1 (en) | Medicament for treating intestinal diseases | |
AU2002239664A1 (en) | Method for drug development using individual patient response | |
AU2003210266A1 (en) | Treatment, diagnosis and imaging of disease | |
MXPA03006249A (es) | Derivados de 2-arilimino-2,3-dihidrotiazoles, sus procesos de preparacion y su uso terapeutico. | |
AU2002233407A1 (en) | 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof | |
AU2002329784A1 (en) | Molecules for disease detection and treatment | |
ZA200110271B (en) | Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylatic methods. | |
AU4654500A (en) | Prevention, diagnosis and treatment of lyme disease | |
AU4418400A (en) | Treatment, imaging and diagnosis of disease using an agent which binds alfa5-integrin | |
AU2002364890A1 (en) | Molecules for disease detection and treatment | |
AU2001277737A1 (en) | Novel substance having physiological activity, process for producing the same, and use | |
AU2001241709A1 (en) | Molecules for disease detection and treatment |